Physiological suppression of the temperature-sensitive sporulation defect in a Bacillus subtilis RNA polymerase mutant

Summary

Five hundred putative RNA polymerase mutants of Bacillus subtilis were isolated by selecting for resistance to the RNA polymerase inhibitors rifampin (Rif^r), streptovaricin (Str^r) or streptolydigan (Std^r). This collection was screened for mutants that were unable to sporulate at the non-permissive temperature of 46°C, yet which sporulated well at 37°C and had normal vegetative growth (Spo^ts phenotype). Nearly one half of the Rif^r and one quarter of the Stv^r mutants were Spo^ts, whereas none of the Std^r mutants had this phenotype.

The streptovaricin resistant strain stv84 was studied in detail. The stv84 mutation maps between cysA14 and strA39 on the B. subtilis chromosome, and the Stv^r and Spo^ts phenotypes cotransform at a frequency of 100%. The Spo^ts phenotype of stv84 could be physiologically corrected by supplementing the growth medium with inhibitors of RNA synthesis such as rifampin or azauracil, with carbohydrates such as ribose, mannose or glycerol, or with lipids such as Tween 40 or fatty acids native to Bacillus subtilis membranes. A Spo^ts phenotype resembling that of stv84 was produced in wild type B. subtilis by adding cerulenin, an inhibitor of fatty acid biosynthesis, to the growth medium. This cerulenin-induced sporulation defect was reversed by the same treatments that correct the temperature-sensitive genetic defect of stv84. These data indicate that the Spo^ts phenotype of strain stv84 is not due to an intrinsic inability of the mutant RNA polymerase to transcribe developmentally-specific genes at the nonpermissive temperature. Rather, the data suggest that the stv84 lesion causes a physiological imbalance which disrupts membrane structure or function in sporulating cells.